S055 Chronic Pruritus: Bedside to Bench Perspectives
DESCRIPTION
Itch impacts quality of life to the same extent as chronic pain. Advances in understanding itch has resulted in a revolution in therapies. This session is geared toward the practicing physician. It addresses particularly challenging topics including female and male genital itches, itch in autoimmune diseases, and itch associated with immunomodulators used to treat malignancies. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuing Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Summarize the pathophysiology of itch so as to formulate practical management of itches.
Utilize new drugs that target itch pathophysiology
Evaluate and manage challenging acute and chronic itches
SCHEDULE
9:00 AM
Paths to defeating itch
Ethan A. Lerner, MD, PhD, FAAD
9:20 AM
Measuring itch
Emily Cole, MD, MPH, FAAD
9:45 AM
When stress gets under your skin
Sonja Stander, MD, IFAAD
10:10 AM
Vulvar itch
Shehla Admani, MD, FAAD
10:35 AM
Genital itch in men
Walter Liszewski, MD, FAAD
11:00 AM
Itch in autoimmunity
Chirag Vasavda, MD
11:25 AM
Itches in immuno-oncology
Yevgeniy Semenov, MD, MS, FAAD
DIRECTOR
Ethan A. Lerner, MD, PhD, FAAD
SPEAKERS
Shehla Admani, MD, FAAD
Emily Cole, MD, MPH, FAAD
Walter Liszewski, MD, FAAD
Yevgeniy Semenov, MD, MS, FAAD
Sonja Stander, MD, IFAAD
Chirag Vasavda, MD
DISCLOSURES
Shehla Admani, MD, FAAD
Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria);
Emily Cole, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
Ethan A. Lerner, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Walter Liszewski, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Eli Lilly – Speaker(Honoraria); Galderma – Speaker(Honoraria); Incyte – Consultant (1099 relationship)(Honoraria); Leo Foundation – Consultant (1099 relationship)(Honoraria); Regeneron – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Honoraria);
Yevgeniy Semenov, MD, MS, FAAD
Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria); Journal of the American Academy of Dermatology – Other(Salary); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria);
Sonja Stander, MD, IFAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Almirall – Consultant(Honoraria), Investigator(Grants/Research Funding); Beiersdorf, Inc. – Consultant(Honoraria); Bellus Health – Consultant(Honoraria); BMS – Speaker(Honoraria); Cara Therapeutics – Consultant(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Galderma – Speaker(Honoraria); Galderma Laboratories, LP – Consultant(Honoraria); Galderma Research & Development, LLC – Consultant(Honoraria); Galderma USA – Investigator(Grants/Research Funding); Incyte – Consultant (1099 relationship)(Honoraria); Kiniksa Pharmaceuticals, Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Investigator(Grants/Research Funding), Speaker(Honoraria); Novartis – Consultant(Honoraria), Speaker(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi Aventis – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant (1099 relationship)(Honoraria); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria); UCB – Speaker(Honoraria); University Hospital Muenster – Advisory Board(No Compensation Received); Vifor Pharma – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); WebMD – Consultant (1099 relationship)(Honoraria);
Chirag Vasavda, MD
AstraZeneca – Consultant (1099 relationship)(Salary); SereNeuro Therapeutics – Advisory Board(No Compensation Received);